Literature DB >> 33144202

Antimicrobial stewardship in the emergency department: characteristics and evidence for effectiveness of interventions.

Larissa May1, Alejandro Martín Quirós2, Jaap Ten Oever3, Jacobien Hoogerwerf3, Teske Schoffelen3, Jeroen Schouten4.   

Abstract

BACKGROUND: Emergency departments (EDs) are the entrance gates for patients presenting with infectious diseases into the hospital, yet most antimicrobial stewardship programmes are primarily focused on inpatient management. With equally high rates of inappropriate antibiotic use, the ED is a frequently overlooked yet important unit for targeted antimicrobial stewardship (AMS) interventions.
OBJECTIVES: We aimed to (a) describe the specific aspects of antimicrobial stewardship in the ED and (b) summarize the findings from improvement studies that have investigated the effectiveness of antimicrobial stewardship interventions in the ED setting. SOURCES: (a) a PubMed search for 'antimicrobial stewardship' and 'emergency department', and (b) published reviews on effectiveness combined with publications from the first source. CONTENT: (a) An in depth analysis of selected publications provided four key antimicrobial use processes typically performed by front-line healthcare professionals in the ED: making a (tentative) clinical diagnosis, starting empirical therapy based on that diagnosis, performing microbiological tests before starting that therapy and following up patients who are discharged from the ED. (b) Further, we discuss the literature on improvement strategies in the ED focusing on guidelines and clinical pathways and multifaceted improvement strategies. We also summarize the evidence of microbiologic culture review. IMPLICATIONS: Based on our review of the literature, we describe four essential elements of antimicrobial use in the ED. Studying the various interventions targeting these care processes, we have found them to be of a variable degree of success. Nonetheless, while there is a paucity of AS studies specifically targeting the ED, there is a growing body of evidence that AS programmes in the ED are effective with modifications to the ED setting. We present key questions for future research.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antibiotic; Antimicrobial; Antimicrobial stewardship; Emergency department; Interventions; Stewardship

Mesh:

Substances:

Year:  2020        PMID: 33144202     DOI: 10.1016/j.cmi.2020.10.028

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

1.  Less is more: Recommendations for achieving best practices in antibiotic use for acute upper respiratory infections.

Authors:  Joe Sills; Eric Boccio; Prasanthi Govindarajan; Youyou Duanmu
Journal:  J Am Coll Emerg Physicians Open       Date:  2022-06-19

2.  Antimicrobial resistance control in the emergency department: a need for concrete improvement.

Authors:  Martin Pin; Rajan Somasundaram; Christian Wrede; Frank Schwab; Petra Gastmeier; Sonja Hansen
Journal:  Antimicrob Resist Infect Control       Date:  2022-07-08       Impact factor: 6.454

3.  Inappropriate Antibiotic Use in Zimbabwe in the COVID-19 Era: A Perfect Recipe for Antimicrobial Resistance.

Authors:  Itai Chitungo; Tafadzwa Dzinamarira; Tinashe K Nyazika; Helena Herrera; Godfrey Musuka; Grant Murewanhema
Journal:  Antibiotics (Basel)       Date:  2022-02-13

4.  The Impact of a Multifaceted Pharmacist-Led Antimicrobial Stewardship Program on Antibiotic Use: Evidence From a Quasi-Experimental Study in the Department of Vascular and Interventional Radiology in a Chinese Tertiary Hospital.

Authors:  Jinhui Xu; Jian Huang; YanXia Yu; Dayong Zhou; Ying Wang; Sudong Xue; Erning Shang; Jiantong Sun; Xinyuan Ding; Lu Shi; Lufen Duan; Lian Tang; Qin Zhou; Xin Li
Journal:  Front Pharmacol       Date:  2022-02-28       Impact factor: 5.810

5.  Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from The Netherlands Pharmacovigilance Centre.

Authors:  Jean Marie Vianney Habarugira; Linda Härmark; Albert Figueras
Journal:  Antibiotics (Basel)       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.